Unlike other companies that manufacture medications and genetic testing products ... is known for developing novel treatments for both in vivo and ex vivo applications. Its flagship program ...

As part of the recently announced portfolio reorganization, NTLA is planning to prioritize the development of its late-stage programs — NTLA-2002 and nexiguran ziclumeran (nex-z). The company ...

and nexiguran ziclumeran (nex-z) for ATTR amyloidosis as it anticipates its first commercial launch in 2027. The discontinued programmes are headed by NTLA-3001, an in vivo CRISPR drug developed ...

The primary aim of this study was to compare in vivo cortical AChE activity prior to and after ... ADRDA criteria for dementia 12 and none of them was taking anticholinergic medications. The subjects ...

Vivo Nex Dual Display Edition mobile was launched in December 2018. The phone comes with a 6.39-inch touchscreen display offering a resolution of 1080x2340 pixels and an aspect ratio of 19.5:9. Vivo ...

The Vivo Y300 5G features a 6.67-inch (2400 ×1080 pixels) Full HD+ E4 AMOLED screen with a 120Hz refresh rate. It is powered by the Snapdragon 4 Gen 2 processor paired with 8GB RAM and up to ...

AK G Type C Wired Earphone For vivo NEX 3 AK G Type C Wired Earphone on sale, Earphones BT 870 for Vivo NEX Earphone Original Like Wired Stereo Deep Bass Head Hands Free Headset v Earbud Calling ...

Vivo has been steadily launching new smartphone models across multiple series in India to expand its portfolio. In the past year, we have seen the addition of the Vivo Z series, U series, and X series ...